GlaxoSmithKline PLC Director/PDMR Shareholding (2743P)
06 Febrero 2019 - 6:20AM
UK Regulatory
TIDMGSK
RNS Number : 2743P
GlaxoSmithKline PLC
06 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Sir Philip Hampton
=== ======================== ============================================
b) Position/status Non-Executive Chairman
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 October
2018 to 31 December 2018.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP14.95 2,926.421
----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2019-02-06
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr Vindi Banga
=== ======================== ============================================
b) Position/status Senior Independent Non-Executive Director
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 October
2018 to 31 December 2018.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP14.95 480.769
----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2019-02-06
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Dr Vivienne Cox
=== ======================== ============================================
b) Position/status Independent Non-Executive Director
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 October
2018 to 31 December 2018.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP14.95 355.351
----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2019-02-06
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Ms Lynn Elsenhans
=== ======================== ===============================================
b) Position/status Independent Non-Executive Director
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 October 2018 to 31 December
2018.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$39.27 1,049.907
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-02-06
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Dr Laurie Glimcher
=== ======================== ===============================================
b) Position/status Independent Non-Executive Director
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 October 2018 to 31 December
2018.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$39.27 1,399.876
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-02-06
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Dr Jesse Goodman
=== ======================== ===============================================
b) Position/status Independent Non-Executive Director
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 October 2018 to 31 December
2018.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$39.27 422.376
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-02-06
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Ms Judy Lewent
=== ======================== ===============================================
b) Position/status Independent Non-Executive Director
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 October 2018 to 31 December
2018.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$39.27 470.648
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-02-06
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr Urs Rohner
=== ======================== ============================================
b) Position/status Independent Non-Executive Director
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 October
2018 to 31 December 2018.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP14.95 480.769
----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2019-02-06
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLQLFBKLFFBBK
(END) Dow Jones Newswires
February 06, 2019 07:20 ET (12:20 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024